KCTD12 and ovarian serous adenocarcinoma: In our study, significant upregulation of Pfetin (KCTD12) was detected in residual tissue from patients with high-grade serous ovarian cancer (HGSOC) who had received neoadjuvant chemotherapy, suggesting a potential role for Pfetin in chemoresistance or tumor aggressiveness.